Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Sch 21420

Known as: Sch-21420 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1993
1993
The in vitro activities of various quinolones, two new aminoglycosides, a new cephamycin analog (cefmetazole) and a new… Expand
  • table 1
1990
1990
Following the use of amikacin as the principal aminoglycoside at a Denver hospital, amikacin resistance appeared first in… Expand
  • table 2
  • table 1
  • table 5
  • table 3
  • table 4
1980
1980
Disk susceptibility tests with two structurally related aminoglycosides (amikacin and Sch 21420) were evaluated. Tests with 10… Expand
  • figure 1
  • figure 2
  • table 2
1980
1980
Sch 21420 is a new aminoglycoside synthesized from gentamicin B. Susceptibility tests with Sch 21420, amikacin, gentamicin… Expand
  • table 3
  • table 4
  • table 5
1979
1979
The nephrotoxic potentials of the new aminoglycoside SCH 21420 and amikacin were compared in a rat model. Groups of rats received… Expand
  • figure 1
  • table 1
1978
1978
Sch 21420, the 1-N-HAPA derivative of gentamicin B, has been compared to gentamicin, tobramycin and amikacin in a variety of in… Expand
1978
1978
In vitro tests were performed with Sch 21420 and Sch 22591 to determine (i) their activity in comparison to six other… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Highly Cited
1978
Highly Cited
1978
The syntheses of 1-N-(S-4-amino-2-hydroxybutyryl)-gentamicin B and 1-N-(S-3-amino-2-hydroxypropionyl)-gentamicin B, designated… Expand
  • table 1
  • table 3
  • table 4
1978
1978
The minimal inhibitory concentration of Sch-21420 closely paralleled amikacin for 125 strains of aerobic gram-negative bacilli… Expand
  • table 1
1978
1978
The activities of Sch 21420 and amikacin were compared in vitro against 448 clinical bacterial isolates and against 82 gentamicin… Expand
  • table 1